{"id":"https://openalex.org/W4226075729","doi":"https://doi.org/10.1017/s1744133122000068","title":"Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals","display_name":"Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals","alternate_titles":[],"publication_year":2022,"publication_date":"2022-04-06","ids":{"openalex":"https://openalex.org/W4226075729","doi":"https://doi.org/10.1017/s1744133122000068","pmid":"https://pubmed.ncbi.nlm.nih.gov/35382921"},"language":"en","primary_location":{"id":"doi:10.1017/s1744133122000068","doi":"https://doi.org/10.1017/s1744133122000068","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1744133122000068","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/573321297A6970CBB89C325D181637D8/S1744133122000068a.pdf/div-class-title-pricing-strategies-executive-committee-power-and-negotiation-leverage-in-new-zealand-s-containment-of-public-spending-on-pharmaceuticals-div.pdf","source":{"id":"https://openalex.org/S78689143","display_name":"Health Economics Policy and Law","issn_l":"1744-1331","issn":["1744-1331","1744-134X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["abdc-b","anvur-scientific","cwts-core","doaj","dongbi-b","erih-plus","jufo-2","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Economics, Policy and Law","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4226075729"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/573321297A6970CBB89C325D181637D8/S1744133122000068a.pdf/div-class-title-pricing-strategies-executive-committee-power-and-negotiation-leverage-in-new-zealand-s-containment-of-public-spending-on-pharmaceuticals-div.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Ben Main","orcid":"https://orcid.org/0000-0002-0009-6116","observed_orcids":["https://orcid.org/0000-0002-0009-6116"]},"institutions":[{"id":"https://openalex.org/I190082696","display_name":"Durham University","ror":"https://ror.org/01v29qb04","country_code":"GB","type":"education","lineage":["https://openalex.org/I190082696"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ben Main","raw_affiliation_strings":["Department of Sociology, University of Durham, Durham, UK"],"raw_orcid":"https://orcid.org/0000-0002-0009-6116","affiliations":[{"raw_affiliation_string":"Department of Sociology, University of Durham, Durham, UK","institution_ids":["https://openalex.org/I190082696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075770685","display_name":"Marcell Csan\u00e1di","orcid":"https://orcid.org/0000-0002-5724-639X","observed_orcids":["https://orcid.org/0000-0002-5724-639X"]},"institutions":[{"id":"https://openalex.org/I4392738183","display_name":"Syreon Research Institute (Hungary)","ror":"https://ror.org/00bsxeq86","country_code":"HU","type":"company","lineage":["https://openalex.org/I4392738183"]}],"countries":["HU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marcell Csanadi","raw_affiliation_strings":["Syreon Research Unit, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syreon Research Unit, Budapest, Hungary","institution_ids":["https://openalex.org/I4392738183"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029934735","display_name":"Piotr Oziera\u0144ski","orcid":"https://orcid.org/0000-0002-2023-3288","observed_orcids":["https://orcid.org/0000-0002-2023-3288"]},"institutions":[{"id":"https://openalex.org/I51601045","display_name":"University of Bath","ror":"https://ror.org/002h8g185","country_code":"GB","type":"education","lineage":["https://openalex.org/I51601045"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Piotr Ozieranski","raw_affiliation_strings":["Department of Sociology, University of Bath, Bath, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Sociology, University of Bath, Bath, UK","institution_ids":["https://openalex.org/I51601045"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I190082696"],"apc_list":{"value":3255,"currency":"USD","value_usd":3255},"apc_paid":{"value":3255,"currency":"USD","value_usd":3255},"fwci":0.4421,"has_fulltext":true,"cited_by_count":13,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.5331725,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":98},"biblio":{"volume":"17","issue":"3","first_page":"348","last_page":"365"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11531","display_name":"Healthcare Systems and Reforms","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-cost-containment","display_name":"drug cost containment","score":0.8389999866485596},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.621999979019165},{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.6819999814033508},{"id":"https://openalex.org/keywords/pharmac","display_name":"PHARMAC","score":0.8529999852180481},{"id":"https://openalex.org/keywords/product-bundling","display_name":"bundling","score":0.7720000147819519},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.8700000047683716},{"id":"https://openalex.org/keywords/patented-drugs","display_name":"patented drugs","score":0.7009999752044678},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.7549999952316284},{"id":"https://openalex.org/keywords/pharmaceutical-expenditure","display_name":"pharmaceutical expenditure","score":0.6840000152587891},{"id":"https://openalex.org/keywords/institutional-design","display_name":"institutional design","score":0.7049999833106995},{"id":"https://openalex.org/keywords/new-zealand","display_name":"New Zealand","score":0.949999988079071}],"concepts":[{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.7519999742507935},{"id":"https://openalex.org/C199776023","wikidata":"https://www.wikidata.org/wiki/Q202875","display_name":"Negotiation","level":2,"score":0.7432000041007996},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6119999885559082},{"id":"https://openalex.org/C9233905","wikidata":"https://www.wikidata.org/wiki/Q3276328","display_name":"Bidding","level":2,"score":0.5888000130653381},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.5274999737739563},{"id":"https://openalex.org/C153083717","wikidata":"https://www.wikidata.org/wiki/Q6535263","display_name":"Leverage (statistics)","level":2,"score":0.5228999853134155},{"id":"https://openalex.org/C2778030619","wikidata":"https://www.wikidata.org/wiki/Q7180762","display_name":"Pharmaceutical policy","level":4,"score":0.35989999771118164},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.3463999927043915},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.3434000015258789},{"id":"https://openalex.org/C2776473838","wikidata":"https://www.wikidata.org/wiki/Q174165","display_name":"Innovator","level":3,"score":0.33239999413490295},{"id":"https://openalex.org/C40700","wikidata":"https://www.wikidata.org/wiki/Q1411783","display_name":"Industrial organization","level":1,"score":0.3248000144958496},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.3199000060558319},{"id":"https://openalex.org/C2780193402","wikidata":"https://www.wikidata.org/wiki/Q3394670","display_name":"Pricing strategies","level":2,"score":0.3050000071525574},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.3043000102043152},{"id":"https://openalex.org/C109986646","wikidata":"https://www.wikidata.org/wiki/Q546113","display_name":"Public policy","level":2,"score":0.2973000109195709},{"id":"https://openalex.org/C108713360","wikidata":"https://www.wikidata.org/wiki/Q1824206","display_name":"Supply chain","level":2,"score":0.2937999963760376},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.29330000281333923},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.29010000824928284},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.271699994802475},{"id":"https://openalex.org/C147859227","wikidata":"https://www.wikidata.org/wiki/Q294217","display_name":"Public sector","level":2,"score":0.26930001378059387},{"id":"https://openalex.org/C32896092","wikidata":"https://www.wikidata.org/wiki/Q189447","display_name":"Risk management","level":2,"score":0.26829999685287476},{"id":"https://openalex.org/C2908795282","wikidata":"https://www.wikidata.org/wiki/Q7240896","display_name":"Drug pricing","level":2,"score":0.2667999863624573},{"id":"https://openalex.org/C47344431","wikidata":"https://www.wikidata.org/wiki/Q1519812","display_name":"Health policy","level":3,"score":0.26649999618530273},{"id":"https://openalex.org/C2781127519","wikidata":"https://www.wikidata.org/wiki/Q43637","display_name":"Monopoly","level":2,"score":0.26249998807907104},{"id":"https://openalex.org/C8505890","wikidata":"https://www.wikidata.org/wiki/Q605095","display_name":"Budget constraint","level":2,"score":0.2619999945163727},{"id":"https://openalex.org/C199728807","wikidata":"https://www.wikidata.org/wiki/Q2578557","display_name":"Equity (law)","level":2,"score":0.2558000087738037}],"mesh":[{"descriptor_ui":"D003363","descriptor_name":"Cost Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009520","descriptor_name":"New Zealand","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017008","descriptor_name":"Negotiating","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1017/s1744133122000068","doi":"https://doi.org/10.1017/s1744133122000068","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1744133122000068","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/573321297A6970CBB89C325D181637D8/S1744133122000068a.pdf/div-class-title-pricing-strategies-executive-committee-power-and-negotiation-leverage-in-new-zealand-s-containment-of-public-spending-on-pharmaceuticals-div.pdf","source":{"id":"https://openalex.org/S78689143","display_name":"Health Economics Policy and Law","issn_l":"1744-1331","issn":["1744-1331","1744-134X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["abdc-b","anvur-scientific","cwts-core","doaj","dongbi-b","erih-plus","jufo-2","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Economics, Policy and Law","raw_type":"journal-article"},{"id":"pmid:35382921","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35382921","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health economics, policy, and law","raw_type":"Journal Article"},{"id":"pmh:oai:https://durham-repository.worktribe.com/:1213008","doi":null,"is_oa":true,"landing_page_url":"https://durham-repository.worktribe.com/output/1213008","pdf_url":"https://durham-repository.worktribe.com/file/1213008/1/Accepted%20Journal%20Article","source":{"id":"https://openalex.org/S4306400188","display_name":"Durham Research Online (Durham University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I190082696","host_organization_name":"Durham University","host_organization_lineage":["https://openalex.org/I190082696"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:oai:dro.dur.ac.uk.OAI2:35516","doi":null,"is_oa":true,"landing_page_url":"http://dro.dur.ac.uk/35516/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400188","display_name":"Durham Research Online (Durham University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I190082696","host_organization_name":"Durham University","host_organization_lineage":["https://openalex.org/I190082696"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Health Economics, Policy and Law, 2022, Vol.17(3), pp.348-365 [Peer Reviewed Journal]","raw_type":"Article"},{"id":"pmh:oai:durham-repository.worktribe.com:1213008","doi":null,"is_oa":true,"landing_page_url":"https://durham-repository.worktribe.com/file/1213008/1/Accepted%20Journal%20Article","pdf_url":null,"source":{"id":"https://openalex.org/S4306400188","display_name":"Durham Research Online (Durham University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I190082696","host_organization_name":"Durham University","host_organization_lineage":["https://openalex.org/I190082696"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:cup:hecopl:v:17:y:2022:i:3:p:348-365_6","doi":null,"is_oa":false,"landing_page_url":"https://www.cambridge.org/core/product/identifier/S1744133122000068/type/journal_article","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":{"id":"doi:10.1017/s1744133122000068","doi":"https://doi.org/10.1017/s1744133122000068","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1744133122000068","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/573321297A6970CBB89C325D181637D8/S1744133122000068a.pdf/div-class-title-pricing-strategies-executive-committee-power-and-negotiation-leverage-in-new-zealand-s-containment-of-public-spending-on-pharmaceuticals-div.pdf","source":{"id":"https://openalex.org/S78689143","display_name":"Health Economics Policy and Law","issn_l":"1744-1331","issn":["1744-1331","1744-134X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["abdc-b","anvur-scientific","cwts-core","doaj","dongbi-b","erih-plus","jufo-2","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Economics, Policy and Law","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4226075729.pdf","grobid_xml":"https://content.openalex.org/works/W4226075729.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W409344806","https://openalex.org/W1969764634","https://openalex.org/W1976814495","https://openalex.org/W1983057256","https://openalex.org/W1996541217","https://openalex.org/W2009093886","https://openalex.org/W2009629544","https://openalex.org/W2047287480","https://openalex.org/W2075718768","https://openalex.org/W2093918016","https://openalex.org/W2123699208","https://openalex.org/W2138664283","https://openalex.org/W2140099882","https://openalex.org/W2143254712","https://openalex.org/W2340285710","https://openalex.org/W2401823228","https://openalex.org/W2414602490","https://openalex.org/W2490999449","https://openalex.org/W2513403311","https://openalex.org/W2520491083","https://openalex.org/W2563937379","https://openalex.org/W2565587258","https://openalex.org/W2604289185","https://openalex.org/W2612793773","https://openalex.org/W2739005947","https://openalex.org/W2742733964","https://openalex.org/W2746434642","https://openalex.org/W2782910846","https://openalex.org/W2783304750","https://openalex.org/W2790820059","https://openalex.org/W2805134576","https://openalex.org/W2883084383","https://openalex.org/W2909660049","https://openalex.org/W2948182932","https://openalex.org/W2951651828","https://openalex.org/W2964275712","https://openalex.org/W2997074688","https://openalex.org/W2999258267","https://openalex.org/W3123911800","https://openalex.org/W3139255709","https://openalex.org/W3178252603","https://openalex.org/W6980665079"],"related_works":["https://openalex.org/W55650361","https://openalex.org/W2953596264","https://openalex.org/W1735236172","https://openalex.org/W2937195477","https://openalex.org/W3138073345","https://openalex.org/W3178252603","https://openalex.org/W3086187747","https://openalex.org/W3134417189","https://openalex.org/W2149410143","https://openalex.org/W1986034453"],"abstract_inverted_index":{"This":[0],"paper":[1],"explores":[2],"policy":[3,31,47,229],"mechanisms":[4,169],"behind":[5],"New":[6],"Zealand's":[7],"remarkable":[8],"track":[9],"record":[10],"of":[11,29,54,77,93,100,134,159,188,192,201,204],"cost":[12,167],"containment":[13,168],"in":[14,43,127,171],"public":[15,79,213],"pharmaceutical":[16,73,86,114,149,205,239],"spending,":[17],"contrasting":[18],"with":[19],"most":[20,96],"other":[21],"advanced":[22],"economies.":[23],"We":[24,38,164],"drew":[25],"on":[26,75,146,186],"a":[27,51],"review":[28],"official":[30],"documents":[32],"and":[33,45,66,107,178],"28":[34],"semi-structured":[35],"expert":[36],"interviews.":[37],"found":[39],"that":[40,155,195],"decision":[41],"making":[42],"pricing":[44,94,122,175,209],"reimbursement":[46,65,180,194],"was":[48,129,151],"dominated":[49],"by":[50,211,238],"small":[52],"group":[53],"managers":[55,89],"at":[56],"the":[57,62,78,132,157,160,172,189,198,234],"Pharmaceutical":[58],"Management":[59],"Agency":[60],"(PHARMAC),":[61],"country's":[63],"drug":[64,193],"Health":[67],"Technology":[68],"Assessment":[69],"Agency,":[70],"who":[71],"negotiated":[72],"prices":[74,87,150],"behalf":[76],"payer.":[80],"In":[81],"formal":[82],"negotiation":[83],"over":[84,148],"patented":[85],"these":[88],"applied":[90],"an":[91,135,152],"array":[92],"strategies,":[95,210],"notably,":[97],"'bundling'":[98],"consisting":[99,170],"discounted":[101],"package":[102],"deals":[103],"for":[104,117,124,139,222],"multiple":[105],"pharmaceuticals,":[106],"'play-off":[108],"tenders',":[109],"whereby":[110],"two":[111,166],"or":[112,227],"more":[113],"companies":[115],"bid":[116],"exclusive":[118],"contracts.":[119,141],"The":[120],"key":[121],"strategy":[123,154,176],"generic":[125],"drugs,":[126],"contrast,":[128],"'blind-tenders'":[130],"taking":[131],"form":[133],"annual":[136],"bidding":[137],"process":[138],"supply":[140],"An":[142],"additional":[143],"contextual":[144],"condition":[145],"bargaining":[147],"indirect":[153],"involved":[156],"cultivation":[158],"PHARMAC's":[161],"'negotiation":[162],"leverage'.":[163],"derived":[165],"relationship":[173],"between":[174],"options":[177],"various":[179],"actors.":[181],"Our":[182],"findings":[183],"shed":[184],"light":[185],"aspects":[187],"institutional":[190],"design":[191],"may":[196],"promote":[197],"effective":[199],"use":[200],"competitive":[202],"negotiations":[203],"prices,":[206],"including":[207],"specific":[208],"specialist":[212],"payer":[214],"institutions.":[215],"On":[216],"this":[217],"basis,":[218],"we":[219],"formulate":[220],"recommendations":[221],"countries":[223],"seeking":[224],"to":[225,231],"develop":[226],"reform":[228],"frameworks":[230],"better":[232],"meet":[233],"budgetary":[235],"challenge":[236],"posed":[237],"expenditure.":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4226075729","counts_by_year":[{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2022-05-05T00:00:00"}
